Related Experiment Video
Updated: Jun 13, 2026
05:25
Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test
Published on: July 14, 2023
Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease
Peter D Burbelo1, Alexandra T Issa, Kathryn H Ching
1Neurobiology and Pain Therapeutics Section, 49 Convent Drive, Building 49, Room 1C20, NIDCR, NIH, Bethesda, MD 20892-4410, USA. burbelop@nidcr.nih.gov
Clinical and Vaccine Immunology : CVI
|April 16, 2010
Summary
A new luciferase immunoprecipitation system (LIPS) test using a synthetic protein (VOVO) shows high accuracy for diagnosing Lyme disease. This improved serological test offers a quantitative approach for evaluating antibody responses to Borrelia burgdorferi infections.
Area of Science:
- Medical Diagnostics
- Immunology
- Infectious Diseases
Background:
- Lyme disease diagnosis requires improved serological tests.
- Current methods for detecting Borrelia burgdorferi antibodies have limitations.
Purpose of the Study:
- To evaluate the efficacy of luciferase immunoprecipitation systems (LIPS) for profiling antibody responses to Borrelia burgdorferi antigens.
- To develop a more accurate diagnostic tool for Lyme disease.
Main Methods:
- Serum samples from patients and controls were profiled using 15 different Borrelia burgdorferi antigen constructs.
- A synthetic protein, VOVO (VlsE-OspC-VlsE-OspC), was developed and tested.
- The VOVO LIPS test was validated on an independent set of 139 serum samples.
Main Results:
- The VOVO LIPS test demonstrated 98% sensitivity and 100% specificity in validation.
- Performance was comparable to the C6 peptide enzyme-linked immunosorbent assay (ELISA).
- The VOVO LIPS test exhibited a wide dynamic range for antibody detection without serum dilution.
Conclusions:
- The VOVO LIPS test is an efficient and quantitative method for diagnosing Lyme disease.
- This LIPS-based approach offers a promising advancement in serological testing for Borrelia burgdorferi infections.
- Further evaluation of LIPS with various antigens could enhance Lyme disease diagnostics.
